Literature DB >> 16533711

Role of pharmacologically active metabolites in drug discovery and development.

Aberra Fura1.   

Abstract

Pharmacologically active metabolites can contribute significantly to the overall therapeutic and adverse effects of drugs. Therefore, to fully understand the mechanism of action of drugs, it is important to recognize the role of active metabolites. Active metabolites can also be developed as drugs in their own right. Using illustrative examples, this paper discusses a variety of biotransformation reactions that produce active metabolites and their structure-activity relationships. The paper also describes the role and significance of active metabolites in drug discovery and development, various experimental observations that can be used as indicators of their presence, and methods that can be used to assess their biological activities and contribution to the overall therapeutic and adverse effects of drugs.

Mesh:

Substances:

Year:  2006        PMID: 16533711     DOI: 10.1016/S1359-6446(05)03681-0

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  24 in total

1.  MS(M), an efficient workflow for metabolite identification using hybrid linear ion trap Orbitrap mass spectrometer.

Authors:  Robert Cho; Yingying Huang; Jae C Schwartz; Yan Chen; Timothy J Carlson; Ji Ma
Journal:  J Am Soc Mass Spectrom       Date:  2012-02-14       Impact factor: 3.109

2.  Intranasal delivery--modification of drug metabolism and brain disposition.

Authors:  Yin Cheong Wong; Zhong Zuo
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

3.  Investigations on the 4-quinolone-3-carboxylic acid motif part 5: modulation of the physicochemical profile of a set of potent and selective cannabinoid-2 receptor ligands through a bioisosteric approach.

Authors:  Claudia Mugnaini; Stefania Nocerino; Valentina Pedani; Serena Pasquini; Andrea Tafi; Maria De Chiaro; Luca Bellucci; Massimo Valoti; Francesca Guida; Livio Luongo; Stefania Dragoni; Alessia Ligresti; Avraham Rosenberg; Daniele Bolognini; Maria Grazia Cascio; Roger G Pertwee; Ruin Moaddel; Sabatino Maione; Vincenzo Di Marzo; Federico Corelli
Journal:  ChemMedChem       Date:  2012-03-02       Impact factor: 3.466

4.  Synthesis and Evaluation of the Metabolites of AMG 221, a Clinical Candidate for the Treatment of Type 2 Diabetes.

Authors:  Aiwen Li; Chester C Yuan; David Chow; Michelle Chen; Maurice G Emery; Clarence Hale; Xiping Zhang; Raju Subramanian; David J St Jean; Renee Komorowski; Murielle Véniant; Minghan Wang; Christopher Fotsch
Journal:  ACS Med Chem Lett       Date:  2011-09-13       Impact factor: 4.345

5.  Metabolism of a Kratom Alkaloid Metabolite in Human Plasma Increases Its Opioid Potency and Efficacy.

Authors:  Shyam H Kamble; Francisco León; Tamara I King; Erin C Berthold; Carolina Lopera-Londoño; Kanumuri Siva Rama Raju; Aidan J Hampson; Abhisheak Sharma; Bonnie A Avery; Lance R McMahon; Christopher R McCurdy
Journal:  ACS Pharmacol Transl Sci       Date:  2020-07-31

6.  Cytochrome P450 Enzyme Metabolites in Lead Discovery and Development.

Authors:  Sylvie E Kandel; Larry C Wienkers; Jed N Lampe
Journal:  Annu Rep Med Chem       Date:  2014       Impact factor: 1.059

7.  Promoting Angiogenesis Effect and Molecular Mechanism of Isopropyl Caffeate (KYZ), a Novel Metabolism-Derived Candidate Drug, Based on Integrated Network Pharmacology and Transgenic Zebrafish Models.

Authors:  Haotian Kong; Songsong Wang; Yougang Zhang; Yangtengjiao Zhang; Qiuxia He; Rong Dong; Xiaohui Zheng; Kechun Liu; Liwen Han
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

8.  Projection of exposure and efficacious dose prior to first-in-human studies: how successful have we been?

Authors:  Christine Huang; Ming Zheng; Zheng Yang; A David Rodrigues; Punit Marathe
Journal:  Pharm Res       Date:  2007-09-25       Impact factor: 4.200

9.  SAR of a new antischistosomal urea carboxylic acid.

Authors:  Jianbo Wu; Chunkai Wang; Cécile Häberli; Karen L White; David M Shackleford; Gong Chen; Yuxiang Dong; Susan A Charman; Jennifer Keiser; Jonathan L Vennerstrom
Journal:  Bioorg Med Chem Lett       Date:  2018-10-25       Impact factor: 2.823

10.  Detection of nanolevel drug metabolites in an organotypic culture of primary human hepatocytes and porcine hepatocytes with special reference to a two-compartment model.

Authors:  Ali Acikgöz; Shibashish Giri; Augustinus Bader
Journal:  Int J Nanomedicine       Date:  2012-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.